In summary, these findings demonstrate the dual therapeutic potential of Cys-hMnO2@GOx@EM-CD24 nanoparticles in suppressing both primary tumor growth and pulmonary metastasis, laying a solid foundation for their future clinical translation in cancer therapy. This evidence concerns the gene CD24 and cancer.